Company Name : Memphis Pharmaceuticals ISIN Code : EGS38351C010 Reuters Code : MPCI.CA Content : The Board of Directors' decisions held on 10/05/2026. News Attachment 1 (631 KB) News Attachment 2 (13,690 KB) News Attachment 3 (2,341 KB) News Attachment 1 (631 KB) News Attachment 2 (13,690 KB) News Attachment 3 (2,341 KB)